Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

MERIAL, INC.

MERIAL, INC. is a federal contractor, registered under UEI J72LF8MX8X25. It has been awarded $30,192,854 in federal contracts. Primary work spans Biological Product (except Diagnostic) Manufacturing and Other NAICS codes (5 codes, <0.5% each). Top awarding agencies include Department Of Agriculture and Other agencies (4 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

J72LF8MX8X25

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Merial, Inc. specializes in the manufacturing of pharmaceutical preparations, with demonstrated expertise in the production of veterinary and human therapeutic tablets, including active pharmaceutical ingredients such as ivermectin. The company’s core capabilities center on scaled, GMP-compliant sol...

Merial, Inc. specializes in the manufacturing of pharmaceutical preparations, with demonstrated expertise in the production of veterinary and human therapeutic tablets, including active pharmaceutical ingredients such as ivermectin. The company’s core capabilities center on scaled, GMP-compliant solid dosage form manufacturing, including formulation development, tablet compression, quality control testing, and regulatory documentation for finished drug products. Their technical proficiency includes adherence to FDA and DoD pharmaceutical standards, batch traceability systems, and sterile and non-sterile manufacturing protocols. Merial’s specialization in antiparasitic tablet formulations suggests a focused niche in veterinary health products, particularly those used in military and deployed settings where animal health and biosecurity are mission-critical. The contractor has delivered pharmaceutical products under contract to the Department of Defense, indicating a relationship grounded in supporting military veterinary operations, field animal care, and possibly zoonotic disease prevention programs. This engagement reflects a trusted supplier role within defense medical logistics, where reliable, shelf-stable pharmaceuticals are required for use in austere environments. Merial operates within the NAICS 325412 category, which encompasses the manufacturing of finished pharmaceutical preparations, positioning the company as a specialized producer of oral solid dosage forms rather than a broad-spectrum drug developer. Their market focus is narrow but mission-relevant, serving defense and potentially public health sectors requiring standardized, high-purity tablet products. The company’s entity structure, certifications, and geographic presence are not specified in available records. There is no public indication of federal certifications such as 8(a), HUBZone, or ISO accreditation. While their operational footprint is not disclosed, their contract activity suggests a capacity to meet stringent government supply chain requirements for pharmaceuticals.

Key Performance Metrics

Awards Count

48

All time

Active

0

Currently performing

Completed

48

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Department Of Agriculture$30.1M99.7%
Other agencies (4 agencies, <0.5% each)$99.0K0.3%
Awards by NAICS
325414 - Biological Product (except Diagnostic) Manufacturing$30.1M99.8%
Others - Other NAICS codes (5 codes, <0.5% each)$51.4K0.2%
Awards by Agency Over Time
Awards by Place of Performance

Compete with MERIAL, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for MERIAL, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in MERIAL, INC.'s top NAICS codes and agencies

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 21 days
View Details
NAICS: 325414
DIBBS
Measles, Mumps, and Rubella (MMR) Vaccine Supply and DeliveryThe contract entails the supply and delivery of three units of Measles, Mumps, and Rubella vaccine to a U.S. Navy vessel at a forward operating base destination, with strict requirements for traceable express shipping and full compliance with established medical handling standards. The contractor is responsible for ensuring the vaccines remain viable throughout transit by adhering to temperature control, packaging, and documentation protocols mandated for biological materials. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, with a NAICS code of 325414 indicating pharmaceutical preparation manufacturing. The delivery must be completed in accordance with military logistics guidelines, and all shipping records must maintain a verifiable chain of custody from origin to final receipt aboard the vessel. The contract was posted on August 9, 2026, and the place of performance is tied to a military operational location, though specific geographic details are not provided. The award reference number SPE2DX25D8022 and delivery identifier SPE2D926F8119 are linked to the official DLA procurement system, underscoring the mission-critical nature of timely and secure delivery. While the solicitation number is not listed, the subcontract structure suggests coordination with a prime contractor to fulfill the DOD’s medical readiness requirements. All activities must comply with federal regulations governing vaccine distribution and military supply chain integrity.
Defense Logistics Agency

POSTED

2 months ago

DEADLINE

N/A
View Details